These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26135794)

  • 1. Anti-viral therapy for congenital cytomegalovirus infection: pharmacokinetics, efficacy and side effects.
    Mareri A; Lasorella S; Iapadre G; Maresca M; Tambucci R; Nigro G
    J Matern Fetal Neonatal Med; 2016; 29(10):1657-64. PubMed ID: 26135794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral treatment of cytomegalovirus infection and resistant strains.
    Schreiber A; Härter G; Schubert A; Bunjes D; Mertens T; Michel D
    Expert Opin Pharmacother; 2009 Feb; 10(2):191-209. PubMed ID: 19236193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of congenital cytomegalovirus: where are we now?
    Michaels MG
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):441-8. PubMed ID: 17547508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of sequential cytomegalovirus isolates in a patient with lymphoma and failing antiviral therapy.
    Ducancelle A; Belloc S; Alain S; Scieux C; Malphettes M; Petit F; Brouet JC; Sanson Le Pors MJ; Mazeron MC
    J Clin Virol; 2004 Apr; 29(4):241-7. PubMed ID: 15018851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M
    J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral drug resistance of human cytomegalovirus.
    Lurain NS; Chou S
    Clin Microbiol Rev; 2010 Oct; 23(4):689-712. PubMed ID: 20930070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The search for new therapies for human cytomegalovirus infections.
    Prichard MN; Kern ER
    Virus Res; 2011 May; 157(2):212-21. PubMed ID: 21095209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cytomegalovirus diseases.
    Vogel JU; Scholz M; Cinatl J
    Intervirology; 1997; 40(5-6):357-67. PubMed ID: 9675640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, pharmacodynamics and clinical use of valganciclovir in newborns with symptomatic congenital cytomegalovirus infection.
    Stronati M; Lombardi G; Garofoli F; Villani P; Regazzi M
    Curr Drug Metab; 2013 Feb; 14(2):208-15. PubMed ID: 22935067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus infection in patients with HIV infection.
    Cheung TW; Teich SA
    Mt Sinai J Med; 1999 Mar; 66(2):113-24. PubMed ID: 10100416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation.
    Cesaro S; Zhou X; Manzardo C; Buonfrate D; Cusinato R; Tridello G; Mengoli C; Palù G; Messina C
    J Clin Virol; 2005 Oct; 34(2):129-32. PubMed ID: 16157264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is combination antiviral therapy for CMV superior to monotherapy?
    Drew WL
    J Clin Virol; 2006 Apr; 35(4):485-8. PubMed ID: 16387546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus drug resistance.
    Emery VC
    Antivir Ther; 1998; 3(4):239-42. PubMed ID: 10682146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpreting human cytomegalovirus antiviral drug susceptibility testing: the role of mixed virus populations.
    Baldanti F; Biron KK; Gerna G
    J Infect Dis; 1998 Mar; 177(3):823-4. PubMed ID: 9498475
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients.
    Torres-Madriz G; Boucher HW
    Clin Infect Dis; 2008 Sep; 47(5):702-11. PubMed ID: 18652557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for management of cytomegalovirus (CMV) infection after allogeneic bone marrow transplantation: the "doubling of baseline CMV pp65 antigenemia" and the "cidofovir as rescue treatment approaches.
    Castagnola E; Miano M; Morreale G; Cristina E; Chierici M; Lanino E
    Blood; 2001 Sep; 98(5):1627-8; author reply 1628-9. PubMed ID: 11547769
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytomegalovirus infection: the point in 2001.
    Salmon-Ceron D
    HIV Med; 2001 Oct; 2(4):255-9. PubMed ID: 11737406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to antivirals in human cytomegalovirus: mechanisms and clinical significance.
    Pérez JL
    Microbiologia; 1997 Sep; 13(3):343-52. PubMed ID: 9353754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus drug resistance and clinical implications.
    Chou SW
    Transpl Infect Dis; 2001; 3 Suppl 2():20-4. PubMed ID: 11926745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.